Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical

Written by Alan Condon | January 08, 2020 | Print  |

Daniel Lemaitre began his new role as CEO at neurostimulation company BlueWind Medical on Jan. 1.

Three things to know:

1. Previously Mr. Lemaitre served as CEO of CoreValve, which was acquired by Medtronic for $800 million in 2009, and chairman of Bioventus, according to his LinkedIn.

2. He operated as Medtronic's senior vice president of strategy and business development before the CoreValve acquisition.

3. BlueWind develops implantable neurostimulators for the spinal cord, deep brain and occipital nerve, according to its website.

More articles on devices:
Orthopedic clinic faces renewed lawsuit over 2016 cyberattack
Orthopedics unit restructures workforce to boost efficiency — 5 details
Optim Orthopedics performs four free joint replacements 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months